Brief: Sygnis expands its Asian distribution network
Brief: SYGNIS completes rights offering and private placement
Brief: Sygnis signs distribution agreement with Lucigen
Brief: Sygnis signs distribution agreement with Mayflower Bioscience for the US market
Brief: Sygnis plans to issue new shares
Brief: Sygnis reports 9-mth EBIT loss widens to EUR 2.7 mln
Brief: Sygnis signs distribution agreement with LABGENE Scientific for Switzerland
Brief: Sygnis signs non-exclusive distribution agreement for Australia with GeneWorks
Brief: Sygnis signs distribution agreement with Chinese Nanodigmbio Co. Ltd.
Brief: Sygnis H1 EBIT loss widens to 1.67 million euros
Brief: Sygnis signs non-exclusive worldwide license agreement with Thermo Fisher Scientific
Brief: Shareholders support management proposals at Sygnis' AGM with large majority
Brief: Sygnis signs non-exclusive distribution agreement with Scandinavian Biotop Oy
Brief: Sygnis signs second non-exclusive distribution agreement with Welgene Biotech in Taiwan
Brief: Sygnis announces global launch of TruePrime RCA kit
Brief: Sygnis says Genetrix S.L. becomes new majority shareholder
Brief: sygnis Q1 revenues up 19 pct to 76,000 euros
Brief: Sygnis signs non-exclusive distribution agreement with Cambridge Bioscience Ltd
Brief: Sygnis FY 2014 operating loss reduced to 3.2 mln euros